| UniProt ID | INSI1_HUMAN | |
|---|---|---|
| UniProt AC | O15503 | |
| Protein Name | Insulin-induced gene 1 protein | |
| Gene Name | INSIG1 {ECO:0000312|HGNC:HGNC:6083} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 277 | |
| Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein . |
|
| Protein Description | Mediates feedback control of cholesterol synthesis by controlling SCAP and HMGCR. Functions by blocking the processing of sterol regulatory element-binding proteins (SREBPs). Capable of retaining the SCAP-SREBF2 complex in the ER thus preventing it from escorting SREBPs to the Golgi. Initiates the sterol-mediated ubiquitin-mediated endoplasmic reticulum-associated degradation (ERAD) of HMGCR via recruitment of the reductase to the ubiquitin ligase, AMFR/gp78. May play a role in growth and differentiation of tissues involved in metabolic control. May play a regulatory role during G0/G1 transition of cell growth.. | |
| Protein Sequence | MPRLHDHFWSCSCAHSARRRGPPRASAAGLAAKVGEMINVSVSGPSLLAAHGAPDADPAPRGRSAAMSGPEPGSPYPNTWHHRLLQRSLVLFSVGVVLALVLNLLQIQRNVTLFPEEVIATIFSSAWWVPPCCGTAAAVVGLLYPCIDSHLGEPHKFKREWASVMRCIAVFVGINHASAKLDFANNVQLSLTLAALSLGLWWTFDRSRSGLGLGITIAFLATLITQFLVYNGVYQYTSPDFLYIRSWLPCIFFSGGVTVGNIGRQLAMGVPEKPHSD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 16 | Phosphorylation | WSCSCAHSARRRGPP HHHHCHHHHHHHCCC | 12.63 | - | |
| 33 | Ubiquitination | SAAGLAAKVGEMINV CHHHHHHHHCCCEEE | 45.20 | - | |
| 144 | Ubiquitination | AAVVGLLYPCIDSHL HHHHHHHHHHHHHHC | 10.91 | - | |
| 153 | Ubiquitination | CIDSHLGEPHKFKRE HHHHHCCCCCHHHHH | 51.06 | - | |
| 156 | Ubiquitination | SHLGEPHKFKREWAS HHCCCCCHHHHHHHH | 64.39 | 16399501 | |
| 158 | Ubiquitination | LGEPHKFKREWASVM CCCCCHHHHHHHHHH | 54.96 | 16399501 | |
| 161 | Ubiquitination | PHKFKREWASVMRCI CCHHHHHHHHHHHHH | 9.62 | - | |
| 207 | Phosphorylation | LWWTFDRSRSGLGLG HHHHCCCCCCCCCHH | 32.42 | 32322062 | |
| 222 | Phosphorylation | ITIAFLATLITQFLV HHHHHHHHHHHHHHH | 22.35 | - | |
| 273 | Ubiquitination | LAMGVPEKPHSD--- HHCCCCCCCCCC--- | 41.79 | 16399501 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 207 | S | Phosphorylation | Kinase | PCK1 | P35558 | Uniprot |
| 222 | T | Phosphorylation | Kinase | AMPKA1 | Q13131 | PSP |
| - | K | Ubiquitination | E3 ubiquitin ligase | AMFR | Q9UKV5 | PMID:16168377 |
| - | K | Ubiquitination | E3 ubiquitin ligase | RNF139 | Q8WU17 | PMID:20068067 |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 207 | S | Phosphorylation |
| 32322062 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of INSI1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SCAP_HUMAN | SCAP | physical | 12842885 | |
| SRBP2_HUMAN | SREBF2 | physical | 12842885 | |
| SCAP_MOUSE | Scap | physical | 12202038 | |
| SRBP2_HUMAN | SREBF2 | physical | 12202038 | |
| TERA_HUMAN | VCP | physical | 18835813 | |
| FAF2_HUMAN | FAF2 | physical | 18835813 | |
| SCAP_HUMAN | SCAP | physical | 18835813 | |
| AMFR_HUMAN | AMFR | physical | 16168377 | |
| TERA_HUMAN | VCP | physical | 16168377 | |
| HMDH_HUMAN | HMGCR | physical | 16168377 | |
| HMDH_HUMAN | HMGCR | physical | 19458199 | |
| AMFR_HUMAN | AMFR | physical | 17043353 | |
| SCAP_HUMAN | SCAP | physical | 17043353 | |
| AMFR_HUMAN | AMFR | physical | 19815544 | |
| PRS6A_HUMAN | PSMC3 | physical | 19815544 | |
| PSA7_HUMAN | PSMA7 | physical | 19815544 | |
| TERA_HUMAN | VCP | physical | 19815544 | |
| FAF2_HUMAN | FAF2 | physical | 19815544 | |
| INSI1_HUMAN | INSIG1 | physical | 19617589 | |
| INSI2_HUMAN | INSIG2 | physical | 19617589 | |
| ERLN2_HUMAN | ERLIN2 | physical | 21343306 | |
| AMFR_HUMAN | AMFR | physical | 21343306 | |
| PGRC1_HUMAN | PGRMC1 | physical | 15782218 | |
| SCAP_HUMAN | SCAP | physical | 12242332 | |
| SRBP1_HUMAN | SREBF1 | physical | 12242332 | |
| NCPR_HUMAN | POR | physical | 21081644 | |
| HMDH_HUMAN | HMGCR | physical | 24371122 | |
| SCAP_HUMAN | SCAP | physical | 23564452 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Ubiquitylation | |
| Reference | PubMed |
| "Sterol-regulated ubiquitination and degradation of Insig-1 creates aconvergent mechanism for feedback control of cholesterol synthesis anduptake."; Gong Y., Lee J.N., Lee P.C., Goldstein J.L., Brown M.S., Ye J.; Cell Metab. 3:15-24(2006). Cited for: FUNCTION, INTERACTION WITH SCAP AND SREBP2 COMPLEX, UBIQUITINATION ATLYS-156 AND LYS-158, AND MUTAGENESIS OF LYS-156 AND LYS-158. | |